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Fullerene derivatives demonstrate considerable potential for numerous biological applications, such as the effective
inhibition of HIV protease. Recently, they were identified for their ability to indiscriminately block biological ion
channels. A fullerene derivative which specifically blocks a particular ion channel could lead to a new set of drug
leads for the treatment of various ion channel-related diseases. Here, we demonstrate their extraordinary potential
by designing a fullerene which mimics some of the functions of μ-conotoxin, a peptide derived from cone snail
venom which potently binds to the bacterial voltage-gated sodium channel (NavAb). We show, using molecular
dynamics simulations, that the C84 fullerene with six lysine derivatives uniformly attached to its surface is selective
to NavAb over a voltage-gated potassium channel (Kv1.3). The side chain of one of the lysine residues protrudes
into the selectivity filter of the channel, while the methionine residues located just outside of the channel form
hydrophobic contacts with the carbon atoms of the fullerene. The modified C84 fullerene strongly binds to the
NavAb channel with an affinity of 46 nM but binds weakly to Kv1.3 with an affinity of 3 mM. This potent blocker of
NavAb may serve as a structural template from which potent compounds can be designed for the targeting of
mammalian Nav channels. There is a genuine need to target mammalian Nav channels as a form of treatment of
various diseases which have been linked to their malfunction, such as epilepsy and chronic pain.
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Typically, toxins from venomous species such as cone
snails, spiders, and snakes are investigated as possible
drug leads for ion channel blockers. Converting these
toxins to drugs represents a considerable challenge [1].
For example, disulfide bridges in these peptides, abundant
in all toxins, are vulnerable to scrambling and reduction in
certain extracellular environments and therefore must be
replaced [1-4]. Nanomaterials designed to mimic the main
features of these complex toxin structures present excit-
ing opportunities to specifically target a particular ion
channel subtype and may alleviate some of the challenges
of these peptides.
Increasing attention is being given to fullerenes for
biological applications including antiviral and antibacter-
ial agents, antioxidants, vectors for drug/gene delivery,* Correspondence: tamsyn.hilder@anu.edu.au
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© 2013 Hilder and Chung; licensee Springer. Th
Commons Attribution License (http://creativeco
reproduction in any medium, provided the origphotodynamic therapy, enzyme inhibitors, and diagnostics
(e.g., magnetic resonance imaging) [5,6]. For example, ful-
lerene derivatives have been shown to bind to and inhibit
the activity of HIV protease [7]. Fullerenes consist of a hol-
low carbon cage structure formed by 20 to as many as 300
carbon atoms [8,9]. The most abundantly produced are
those with 60 and 70 carbon atoms. Fullerenes are insol-
uble in aqueous solution and aggregate easily. Therefore,
there has been significant work into making these struc-
tures soluble so that they can be utilized for their potential
biomedical applications. One method which increases their
solubility is chemical functionalization with moieties such
as amino acids and carboxylic acid [5]. Fullerene chemistry
has been intensely developed, and the main efforts are now
devoted to broaden their application [6].
In 2003, Park et al. [10] identified non-functionalized car-
bon nanotubes and C60 fullerenes as a novel class of ion
channel blockers. Their experiments on various biological
ion channels demonstrated that these nanostructuresis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Figure 1 [Lys]-fullerene structure. Optimized structure of the
[Lys]-fullerene.
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sium channels depending on their geometric structure
and size. Similarly, experiments by Chhowalla et al. [11]
and Xu et al. [12] demonstrated that functionalized
multi-walled and single-walled carbon nanotubes affected
the activity of ion channels in Chinese hamster ovary
cells (CHO) and undifferentiated pheochromocytoma
(PC12) cells, respectively. Park et al. [10] also examined
the binding of their fullerenes and nanotubes to KcsA
using docking simulations and proposed that the mole-
cules block the entrance to the pore. In contrast,
Kraszewski et al. [13] showed using molecular dynamics
simulations that C60 fullerenes do not bind to the select-
ivity filter. Instead, they demonstrated that C60 fullerenes
bind strongly to the hydrophobic residues of the extracel-
lular loops in the three potassium channels they exam-
ined, namely KcsA, MthK, and Kv1.2, and suggest that
these fullerenes may hinder the function of potassium
channels [13]. Similarly, Monticelli et al. examined the
interaction of a C70 fullerene with the Kv1.2 potassium
channel using molecular dynamics and found that they
made contact with hydrophobic residues in the extracel-
lular or intracellular loops, but not the selectivity filter
[14]. They also examined C70 fullerenes fully coated in
gallic acid to stabilize the fullerenes in solution. These
gallic acid coated fullerenes were also shown to make con-
tact with the extracellular or intracellular loops, but not
the selectivity filter [14]. Monticelli and co-workers [14,15]
have also shown using molecular dynamics that non-
functionalized fullerenes agglomerate within the hydropho-
bic layer of lipid bilayers.
In this paper, we design a fullerene to mimic the struc-
ture of μ-conotoxin, which has been shown to bind with
strong affinity to NavAb [16,17]. Our fullerene molecule,
illustrated in Figure 1, contains 84 carbon atoms and has
six lysine derivatives uniformly attached to its surface. In
essence, the C84 fullerene cage mimics the rigid globular
structure of the μ-conotoxin molecule, and the lysine
derivatives mimic the flexible positively charged arms of
μ-conotoxin which are shown to bind to the channel
and within the selectivity filter of NavAb [16]. By com-
paring the binding of the C84 fullerene derivative to two
membrane ion channels, the voltage-gated potassium
channel Kv1.3 and the bacterial voltage-gated sodium
channel NavAb, we are able to demonstrate its specificity
to NavAb. Kv1.3 is a mammalian voltage-gated potas-
sium channel, whereas NavAb is a voltage-gated sodium
channel present in bacteria. There is a genuine need to
target mammalian voltage-gated sodium channels as a
form of treatment of various diseases which have been
linked to their malfunction, such as epilepsy, neuropathic
pain, and long QT syndrome [18-20]. This work suggests
the possibility of fullerene derivatives as possible drug
leads for the treatment of these diseases. Alternatively,although the function of bacterial voltage-gated sodium
channels is relatively unknown, it has been proposed that
they may play a role in flagella mobility [21]. The flagel-
lum generates chemotaxis which is critical for the cell's
survival [22], as chemotaxis is one of the sensing systems
that bacteria have to monitor and respond to changes in
their environment [23]. Therefore, these fullerene deriva-
tives may also have potential as antibacterial agents.
Methods
Although C60 and C70 fullerenes are the most abundantly
produced in carbon soot, higher fullerenes such as C76,
C78, and C84 have also been isolated [24,25] and are among
the most abundant higher fullerenes [26]. We generate an
initial C84 fullerene molecule using the fullerene library
available in the Nanotube Modeler 1.7.3 software [27]. The
C84 fullerene has six favorable isomers [28], and of these,
the D2 and D2d have the lowest energy [29]. We choose
the structure with D2d symmetry (structure number 23 in
Nanotube Modeler) as this has also been reported as the
most commonly observed in experiments [28]. The C84
fullerene has an approximate diameter of 8 Å.
Ideally, an ion channel blocker design would have flex-
ible side chains which can bind to the channel and block
the entrance to the pore. The D2d isomer of C84 has
been shown to have the most localized π bonding of the
fullerenes that have been isolated and has therefore been
suggested as being the most reactive toward addition re-
actions [28]. Researchers [30-32] have also shown that it
is possible to attach various chemical species to the out-
side of fullerene molecules. For example, phenylalanine
and lysine amino acid derivatives have been attached to
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fullerene structure into ArgusLab 4.0.1 and attach six
lysine derivatives to its outside surface [33]. A similar
water-soluble amino-fullerene derivative with five cysteine
moieties attached to the surface of C60 fullerene has previ-
ously been synthesized and characterized by Hu et al. [34].
They demonstrated the ability of this fullerene derivative to
prevent oxidative-induced cell death without evident tox-
icity [34]. We choose positively charged residues with the
aim of mimicking the function of μ-conotoxin to NavAb.
The distance between nitrogen atoms on opposing lysine
chains is approximately 21 Å.
The modified fullerene (C84(C4H8NH3
+)6 structure is
optimized in ArgusLab [33] and is shown in Figure 1.
The geometry optimizations were performed using de-
fault parameters, the Broyden-Fletcher-Goldfarb-Shanno
algorithm and the universal force field. Restricted Hartree-
Fock method was used, where the molecule is a
closed shell system with all orbitals doubly occupied. All
optimization processes are performed until the Hartree-
Fock self-consistent field converged to 10−10 kcal/mol and
the gradient converged to 10−1 kcal/mol/Å. Throughout
this paper, this modified C84 fullerene is referred to as
[Lys]-fullerene.
The coordinates of NavAb are obtained from the pro-
tein database [PDB:3RVY] [35]. We obtain a homology
model of Kv1.3 using the refined structure of the Kv1.2
channel (PDB:SLUT) as a template [36]. The generation
of the homology model for Kv1.3 is described in detail in
Chen et al. [37], where it was shown to reproduce ex-
perimental conduction properties and binding affinities
to charybdotoxin and ShK. We chose to examine the
binding of the [Lys]-fullerene to Kv1.3, giving us the op-
portunity to directly compare our results with the bind-
ing of polypeptide toxins [37,38].
Molecular dynamics (MD) simulations are used to deter-
mine the bound configuration of the [Lys]-fullerene and
calculate the potential of mean force (PMF) of the [Lys]-
fullerene binding to the channel. All MD simulations are
performed using NAMD 2.8 and visualized using VMD 1.9
[39,40]. Throughout, we use the CHARMM36 force field
[41,42] and TIP3P water, with a time step of 2 fs, at con-
stant pressure (1 atm), and temperature (300 K). The chan-
nel and fullerene complex are embedded in a POPC lipid
bilayer, solvated in approximately a 100 × 100 × 100 Å3
box of water. Potassium/sodium (for Kv1.3/NavAb) and
chloride ions are added to both neutralize the system and
simulate a 250-mM ionic concentration. The protein is ini-
tially held fixed to allow the water and ions to equilibrate
during the simulation period of 0.1 ns, and in subsequent
simulations, the protein and lipid bilayer center of mass is
held by a harmonic constraint of 0.2 kcal/mol/Å2. A similar
methodology has been used to investigate the binding of
toxins to ion channels [16,37,43].The [Lys]-fullerene is initially placed near the entrance
of the selectivity filter (at z = 22 Å) and the system is
allowed to equilibrate for 1 to 3 ns with the fullerene un-
constrained. The PMF for the binding of the [Lys]-fuller-
ene to the NavAb and Kv1.3 channels is determined
using umbrella sampling with this equilibrated structure.
Umbrella sampling windows are generated using steered
MD simulations with a force of 30 kcal/mol/Å applied
to pull the fullerene out of the binding site. During the
steered MD simulations the backbone atoms of the pro-
tein are held fixed and the atoms of the fullerene are
held by a harmonic constraint of 0.2 kcal/mol/Å2 to
maintain the root-mean-square deviation, with reference
to a starting configuration below 0.25 Å so that no sig-
nificant distortion takes place. The channel central axis
(z-axis) is used as the reaction coordinate. Pulling gener-
ates a continuous number of configurations along the
permeation pathway so that umbrella sampling windows
can be constructed every 0.5 Å.
During umbrella sampling the center of mass of the
backbone atoms of the fullerene is confined to be within
a cylinder of 8 and 13 Å centered on the channel axis
for Kv1.3 and NavAb, respectively, and beyond this, a
harmonic potential of 20 kcal/mol/Å2 is applied. These
values are shown to provide adequate sampling. More-
over, a force constant of 30 kcal/mol/Å2 is applied in the
z direction to constrain the center of mass of fullerene
to the sampling window. The center of mass coordinates
of the backbone atoms of the fullerene is saved every
0.5 ps. The PMF is then constructed along the z direction
using the weighted histogram analysis method [44] and the
center of mass coordinates. Each sampling window is run
for 5 ns. The PMF is shown to converge as the depth
changes by less than 0.5 kT when simulations are run for a
further 1 ns.
The dissociation constant (Kd) in the unit of molar is
estimated to be [37,45,46]:
K−1d ¼ 1; 000 NAπR2∫z2z1 exp −W zð Þ=kBTð Þdz; ð1Þ
where W(z) is the 1D PMF with the zero point located
at the bulk, 1,000 NA is used to convert from cubic
meter to liter per mole, kB and T are Boltzmann's con-
stant and temperature, respectively, z1 is in the binding
pocket, and z2 is in the bulk [46]. Although Equation 1
was originally derived for the binding of an ion to a
channel [45], it has also been successfully applied to
toxin binding [16,37,43]. Note that the windows at 38.5
and 42.0 Å for NavAb and Kv1.3, respectively, are as-
sumed to be bulk, and the PMF is therefore set to zero
at this z position. The fullerene is docked to NavAb and
Kv1.3 at z = 20.5 Å and z = 23.0 Å, respectively, and the
center of mass is located at z = 0 Å. A hydrogen bond is
assumed to be formed if the donor-acceptor distance is
Figure 2 Potential of mean force (PMF). PMF for the cleavage of
[Lys]-fullerene from the NavAb and Kv1.3 channels.
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is ≥150. A salt bridge is formed between the fullerene and
ion channel if the distance between any of the nitrogen
atoms on the fullerene side chains and the oxygen atoms
of an acidic residue on the ion channel is <4 Å.
Results and discussion
Figure 2 illustrates the PMF for the cleavage of [Lys]-
fullerene from the NavAb and Kv1.3 channels. The axial
position in Figure 2 is measured from the center of mass
of the channel to that of the [Lys]-fullerene. The PMF
reaches a minimum at 20.5 Å for NavAb, with a wellFigure 3 Binding of [Lys]-fullerene to the outer vestibule of NavAb. (A
coordinating the [Lys]-fullerene molecule. Note that the lysine side chains o
illustrating the Met181 residues and Glu177 interaction with one of the lysidepth of −18.7 kT. For Kv1.3, the PMF reaches a mini-
mum at 23.0 Å, with a well depth of −7.1 kT. We find
that the binding between [Lys]-fullerene and both NavAb
and Kv1.3 is stable and so all 5 ns of umbrella sampling is
used. It is assumed that the properties for the window at
38.5 and 42.0 Å for NavAb and Kv1.3, respectively, are
similar to those in bulk, and therefore, the PMF is set to
0 at this point.
Using Equation 1, we obtain dissociation constants,
Kd, of 46 nM and 3 mM for the NavAb and Kv1.3 chan-
nels, respectively. In comparison, in MD simulations,
Chen and Chung [16] found that μ-conotoxin binds to
NavAb with a well depth of approximately −25 kT and a
binding affinity of 0.1 nM. French and colleagues [17]
have recently confirmed this result experimentally and
obtained a binding affinity of 0.005 nM for the NaChBac, a
bacterial channel closely related to NavAb. This [Lys]-ful-
lerene mimic of μ-conotoxin is specific to NavAb over
Kv1.3 and presents exciting opportunities for future drug
development research.
To characterize the interactions between the [Lys]-ful-
lerene and the two channels, we examine the umbrella
sampling window located at the minimum of the PMF,
20.5 and 23.0 Å in NavAb and Kv1.3, respectively. Exam-
ining the docked structure to NavAb more closely, we
find that four methionine residues near the entrance to
the pore (located at position 181) form a hydrophobic
interaction with the fullerene surface, ‘coordinating’ the
blocker to the pore, as illustrated in Figure 3A. No water
molecules are present between the Met181 residues and
the fullerene surface. Moreover, one of the lysine side) Top view illustrating the four Met181 residues (shown in grey)
f the [Lys]-fullerene have been removed for clarity. (B) Side view
ne chains of the [Lys]-fullerene.
Table 1 Sequence alignment between Kv1.3, NavAb, and
Nav1.8
Sequence alignment
Kv1.3 V V T M T T V G Y G D Ma
NavAb F Q V M T L E
b S W S Ma G
Nav1.8 I F R L M T Q Db S W E R La
Nav1.8 II F R I L C G Eb W I E N Ma
Nav1.8 III L Q V A T F Kb G W M D Ia
Nav1.8 IV F Q I T T S Ab G W D G La
Kv1.3 and NavAb are homotetramers, and Nav1.8 is a heterotetramer.
bHomologues to Glu177. aPossible homologues to Met181.
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lectivity filter. In NavAb, this side chain binds to the glu-
tamate residue at position 177 (as shown in Figure 3B)
with an average of 0.9 ± 0.6 hydrogen bonds. Glu177
has previously been identified as a blocking site for
tetrodoxins and saxotoxins, and aligns with the glutam-
ate residues that determine selectivity in Nav and Cav
channels [35] (illustrated in the sequence alignment in
Table 1). At approximately 24.5 Å, the [Lys]-fullerene
sits off the center relative to the selectivity filter, bound
to only two of the four Met181 residues. Moreover, the
lysine derivative of the [Lys]-fullerene is no longer oc-
cluding the pore at this distance, allowing an open pore
to occur. As the [Lys]-fullerene moves away from the
pore entrance, the Met181 residues rotate so as to
maximize the hydrophobic interaction until this inter-
action is completely cleaved when the [Lys]-fullerene
reaches a distance of approximately 27.5 Å. The hydro-
phobic interaction between the Met181 residues and the
fullerene surface is the main cause of the strong binding
to the NavAb channel. In density functional calculations,Figure 4 Side view of the binding of [Lys]-fullerene to the outer vesti
the Met450 residues are shown in grey.the free energy of dissociation of methionine from a C60
fullerene is −12.121 kcal/mol [47].
Similarly, by examining the docked structure to Kv1.3,
we observe that one of the lysine side chains of the
[Lys]-fullerene is protruding into the selectivity filter, as
shown in Figure 4, with an average of 0.5 ± 0.8 hydrogen
bonds. In some of the trajectories, one other lysine side
chain makes contact with a glutamate residue on the
outer vestibule at position 420 (shown as red in Figure 4),
but over the entire simulation, there is only an average
of 0.08 ± 0.3 hydrogen bonds between these two resi-
dues. Therefore, it is unlikely that this contact is stable.
There is a methionine (Met450) residue in a similar pos-
ition to the Met181 residues of NavAb, as shown in the
sequence alignment in Table 1. However, in Kv1.3, these
methionine residues are acting to stabilize the channel
and therefore cannot flip outwards towards the fullerene.
In contrast to NavAb, these methionine residues are un-
able to form a hydrophobic interaction with the [Lys]-
fullerene surface, as shown in Figure 4. Amino acid
sequences of the NavAb and Kv1.3 ion channels were
obtained from the National Center for Biotechnology
Information (NCBI) protein database (NCBI:3RVY_A,
NCBI:NP_002223.3, respectively) [35]. The sequences
were aligned using multiple sequence comparison by log-
expectation (MUSCLE) [48].
Bacterial and mammalian channels differ significantly
in both sequence and structure. In an attempt to under-
stand how the [Lys]-fullerene might bind to a mamma-
lian Nav channel, we align the sequence of NavAb to
Nav1.8. Although μ-conotoxin is sensitive to Nav1 chan-
nels, Nav1.8 is both tetrodotoxin and μ-conotoxin in-
sensitive [19,49]. The Nav1.8 sequence has recently been
studied for gain-of-function mutations which have beenbule of Kv1.3. The Glu420 residue on chain A is shown in red, and
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lective blockers of Nav1.8 have been identified, such as
A-803467 and μO-conotoxin, and have been shown to
suppress chronic pain behavior [19,20]. Therefore, it is
interesting to consider the sensitivity of Nav1.8 to [Lys]-
fullerene. Amino acid sequences of the NavAb and
Nav1.8 ion channels were obtained from the NCBI pro-
tein database (NCBI:3RVY_A, NCBI:NP_006505.2, re-
spectively) [35,50], and the sequences were aligned using
MUSCLE [48]. A comparison of the two sequences,
shown in Table 1, demonstrates that Glu177 in NavAb
aligns with the Asp-Glu-Lys-Ala (DEKA) residues of the
selectivity filter of Nav1.8. As mentioned, the four me-
thionine residues at position 181 form hydrophobic
bonds with the fullerene molecule ‘coordinating’ it to the
pore of NavAb. In Nav1.8, there are four hydrophobic
residues in a similar position to Met181 and in particu-
lar Leu-Met-Iso-Leu (LMIL). It may be possible that a
similar hydrophobic bond could form between the fuller-
ene and this mammalian Nav channel. However, in
Kv1.3, the methionine residue does not contribute to the
binding of [Lys]-fullerene and instead stabilizes the chan-
nel. A similar mechanism could occur in Nav1.8. Unfor-
tunately, no crystal structure of Nav1.8 or any other
mammalian Nav channel is currently available. There-
fore, to confirm such a hypothesis requires significant fu-
ture work such as building a Nav1.8 homology model
and conducting molecular dynamics simulations to ascer-
tain the binding affinity of the [Lys]-fullerene.
Carbon-based nanomaterials offer the possibility of
some exciting applications, such as drug delivery, select-
ive cell destructive agents, biosensors, and diagnostics.
Further development is needed regarding the toxicity of
these materials in both biological and environmental en-
vironments, in the short and long terms, for these appli-
cations to be brought into widespread use. We refer the
reader to recent reviews on the use of carbon nanotubes
and fullerenes in biology and medicine [5,6,51]. Typic-
ally, non-functionalized carbon-based nanomaterials are
considered to be toxic, but significant work has been
done to make these structures soluble and biocompatible.
For example, it has been demonstrated that C60 fullerene
with five cysteine residues attached to its surface is water
soluble and does not cause cellular toxicity [34].
As with any drug lead, to move from an idea to a mar-
ketable drug can take between 10 to 15 years. Therefore,
significant research effort is required to develop this theor-
etical [Lys]-fullerene design into a drug for therapeutic use.
Future simulations are required to determine whether
these compounds are potent blockers of mammalian Nav
channels and if they are specific to a particular channel
sub-type. Following this, experiments would need to be
performed to confirm theoretical findings and deter-
mine toxicity profiles. Polypeptide toxins from venomousanimals have evolved over millions of years, aimed at rap-
idly immobilizing and capturing prey. Since they act on a
broad spectrum of ion channel families and are rapidly de-
graded in vivo, converting these toxins to drugs represents
a considerable challenge, and attempts are being made to
synthesize smaller and more durable mimetic structures
[1-4]. The use of nanomaterials, which replace the rigid
backbone of the naturally occurring toxins, may prove to
be a fruitful approach for such an endeavor. In the past,
fullerenes suffered from high production costs which gen-
erated an obstacle to the development of fullerene-based
applications, but the cost has rapidly declined [5].Conclusions
Voltage-gated sodium channels are present throughout
muscle and neuronal cells in mammals. Their dysfunc-
tion has long been linked to disorders such as epilepsy
and chronic pain. Toxins from venomous species such
as cone snails and scorpions have demonstrated activity
against sodium channels. One example is the polypep-
tide toxin μ-conotoxin (PIIIA), extracted from the cone
snail, which has been shown to potently block both bac-
terial and mammalian Nav channels [16,17,52]. Unfortu-
nately, converting toxins to drugs represents a considerable
challenge [1-4]. We attempt to mimic the structure of
μ-conotoxin by (1) replacing its bulky core with a C84
fullerene and (2) chemically attaching positively charged
groups to the fullerene surface. Although fullerenes have
previously been identified as possible ion channel blockers
[10-15], no studies have demonstrated the potential of de-
signing fullerenes through chemical modification to target
specific ion channels. We demonstrate that [Lys]-fullerene
blocks the ion-conducting pathway of the bacterial voltage-
gated sodium channel, NavAb with a strong binding
affinity, similar in magnitude to μ-conotoxin [16], and with
selectivity over potassium voltage-gated channels. This ful-
lerene design may serve as a structural template from
which a new set of potent compounds can be designed
for the treatment of various diseases linked to sodium
channel dysfunction.
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